Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIMA: Optimising Mammography Assesment Via Blood-based Biomarkers

NCT07049822 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT07049822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07049822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIMA: Optimising Mammography Assesment Via Blood-based Biomarkers
Lead sponsor
Vejle Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 24, 2025
Completion date
December 31, 2029
Enrollment
1,200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer